{"id":5254,"date":"2021-06-01T19:34:23","date_gmt":"2021-06-01T17:34:23","guid":{"rendered":"https:\/\/pikralida.eu\/news\/"},"modified":"2022-12-14T18:06:17","modified_gmt":"2022-12-14T17:06:17","slug":"news","status":"publish","type":"page","link":"https:\/\/pikralida.eu\/en\/news\/","title":{"rendered":"News"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

<\/h1>

News<\/span><\/h3>
<\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n
\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Completion of Scientific Advice discussion with Fimea <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 27 March 2023<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 14 November 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Deep Tech Summit <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida on the deeptech map! <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 11 October 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 30 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n New trends in Polish and global pharmacy <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Industries of tomorrow: medical <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 29 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 27 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida receives the Eagle of Innovation award <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n EpiFix on the Innovation Map of the Ministry of Health <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 26 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 23 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n BigPharma Day <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida at scientific conference <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 14 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 07 September 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida in Science|Business magazine <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Polpharma the Contractor for the key stage of the EpiFix project <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 19 July 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 14 June 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida in the report “Top Disruptors in Healthcare 2022” <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida attended Reach4.biz Meetup <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 02 June 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 28 May 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Konference ACCORD 2022 <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida wins an award at CEBioForum <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 26 May 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 18 May 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida on the map of Polish biotechnology companies <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n An interview with the President of Pikralida, Stanis\u0142aw Pikul, in Forbes magazine <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 29 April 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 21 February 2022<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n 3-rd anniversary of Pikralida <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida in the program We’re Changing Greater Poland <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 25 January 2022<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 21 December 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Best wishes! <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n #funduszeUE closer to you! <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 05 December 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 01 December 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n The address of Pikralida changed <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n How to start working in biotechnology? <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 26 October 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 20 October 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Pikralida in \u201cPuls Biznesu\u201d <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n EpiFix \u2013 a breakthrough therapeutic solution preventing the development of post-injury and post-stroke epilepsy <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 06 October 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 29 September 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Award for Pikralida during the Intelligent Development Forum <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n \u201cFrom idea to industry\u201d, or how to develop BioTech in Poland <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 28 September 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 27 September 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n It’s all about the team <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Manufacture of active substances in Poland \u2013 a viable opportunity or a pipe dream? <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 24 September 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 09 August 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Publication “A pharmaceutical strategy for Europe” <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Interview with the founders of the Pikralida startup <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 04 August 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 02 August 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Funding under 1\/1.1.1\/2021 Fast Track competition <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Co-financing from 3\/1.1.1\/2020 Fast Track for Mazovia competition <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 12 July 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 08 June 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Seminar \u2013 Development of Innovative Drugs <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Signing an Agreement for R&D Project Financing <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 24 May 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 23 April 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Seminar \u2013 Planning of a clinical trial <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Effective Cooperation Academia PACTT \u2013 Pfizer <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 27 March 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 13 February 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Effective Cooperation Academia PACTT \u2013 Pfizer <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Signing an Agreement for R&D Project Financing <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n
\n
\n 21 January 2021<\/span>\n <\/div>\n <\/div>\n \n
\n
\n 21 January 2021<\/span>\n <\/div>\n <\/div>\n \n
\n\n
\n
\n <\/span>\n <\/div>\n
\n \n
\n <\/i><\/span>\n <\/div>\n\t\t\n
\n <\/span>\n\n \n
\n

\n \n Signing an Agreement for R&D Project Financing <\/a>\n <\/h4>\n \n More\n <\/a>\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n\n \n <\/div>\n <\/div>\n\n \t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

News Polpharma the Contractor for the key stage of the EpiFix project More 19 lipca 2022 14 czerwca 2022 Pikralida in the report \u201cTop Disruptors in Healthcare 2022\u201d More Pikralida attended Reach4.biz Meetup More 02 czerwca 2022 28 maja 2022 Konference ACCORD 2022 More Pikralida wins an award at CEBioForum More 26 maja 2022 18 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5254","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/pages\/5254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/comments?post=5254"}],"version-history":[{"count":0,"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/pages\/5254\/revisions"}],"wp:attachment":[{"href":"https:\/\/pikralida.eu\/en\/wp-json\/wp\/v2\/media?parent=5254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}